Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pre-menopausal Breast Cancer”

58 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 58 results

Not applicableUnknownNCT05474391
What this trial is testing

MammaPrint Value for Pre-menopausal Breast Cancer Patients

Who this might be right for
Breast Cancer
Fudan University 200
Not applicableStudy completedNCT00188682
What this trial is testing

Breast Study to Determine the Ability of Non-Invasive Optical Transillumination Spectroscopy to Predict Breast Density.

Who this might be right for
Breast Cancer
University Health Network, Toronto 300
Not applicableStudy completedNCT00827307
What this trial is testing

Zoladex Plus Tamoxifen in Breast Cancer

Who this might be right for
MammographyEstrogenLipemia+2 more
Zhejiang Cancer Hospital 100
Testing effectiveness (Phase 2)Study completedNCT04659551
What this trial is testing

Neoadjuvant Chemo-endocrine Therapy and Immunotherapy for Pre-menopausal Luminal B Breast Cancer Patients

Who this might be right for
Breast Cancer
Istituto Oncologico Veneto IRCCS 43
Testing effectiveness (Phase 2)Study completedNCT03056755
What this trial is testing

Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant or Letrozole, Based on Prior Endocrine Therapy, in Patients With PIK3CA Mutant, HR+, HER2- Advanced Breast Cancer Who Have Progressed on or After Prior Treatments

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 383
Not applicableStudy completedNCT00878930
What this trial is testing

Parameters of Acceptability, Compliance and Efficacy of Fulvestrant in Post-menopausal Patients With Advance Breast Cancer

Who this might be right for
Breast Cancer
AstraZeneca 500
Testing effectiveness (Phase 2)Ended earlyNCT01276704
What this trial is testing

Prevention Strategy for Pre-Menopausal Women at High Risk for Development of Breast Cancer

Who this might be right for
Breast Cancer
Carol Fabian, MD 180
Testing effectiveness (Phase 2)Looking for participantsNCT05941520
What this trial is testing

Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer

Who this might be right for
Breast Atypical HyperplasiaBreast CarcinomaBreast Ductal Carcinoma In Situ+1 more
National Cancer Institute (NCI) 80
Testing effectiveness (Phase 2)Study completedNCT00019500
What this trial is testing

Raloxifene in Preventing Breast Cancer in Premenopausal Women

Who this might be right for
Breast Cancer
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT02058381
What this trial is testing

A Phase Ib Dose De-escalation Study With BYL719 in Premenopausal Patients With Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Pre-menopausal Breast CancerPI3K Pathway Inhibition
Novartis Pharmaceuticals 40
Testing effectiveness (Phase 2)Study completedNCT05549505
What this trial is testing

A Trial Using ARV-471 or Anastrozole in Post-Menopausal Women With Breast Cancer Prior to Surgery

Who this might be right for
Breast Cancer
Arvinas Inc. 152
Testing effectiveness (Phase 2)Study completedNCT00235937
What this trial is testing

Study on Pre-menopausal Patients With Advanced ER and PR + BC Treated With Arimidex Plus Zoladex

Who this might be right for
Breast Cancer
AstraZeneca 45
Early research (Phase 1)Looking for participantsNCT06139107
What this trial is testing

RADIANT: Pre-op Radiation With Abemaciclib and Letrozole

Who this might be right for
Breast Cancer
Mridula George, MD 15
Testing effectiveness (Phase 2)Study completedNCT03747042
What this trial is testing

Letrozole in Post-Menopausal Patients With Operable Hormone-Sensitive Breast Cancer

Who this might be right for
Breast Cancer Female
University of Texas Southwestern Medical Center 61
Testing effectiveness (Phase 2)Ended earlyNCT04862143
What this trial is testing

Pilot Decentralized Clinical Trial in Men and Pre and Post-menopausal Women With Breast Cancer and a Specific Mutation (PIK3CA) Treated With Alpelisib in Combination With Fulvestrant

Who this might be right for
Advanced Breast Cancer
Novartis Pharmaceuticals 2
Large-scale testing (Phase 3)Study completedNCT01073865
What this trial is testing

Study to Compare Zoladex™ 10.8 mg With Zoladex 3.6 mg in Pre-menopausal Women With Breast Cancer

Who this might be right for
Breast Cancer
AstraZeneca 222
Testing effectiveness (Phase 2)Study completedNCT00259090
What this trial is testing

Anti-tumour Effects & Tolerability of Faslodex Alone or in Combination With Arimidex in Post Menopausal Women Prior to Surgery for Primary Breast Cancer

Who this might be right for
Breast Cancer
AstraZeneca 120
Testing effectiveness (Phase 2)Study completedNCT00303524
What this trial is testing

Comparative Study of Oestradiol Suppression: Zoladex 10.8mg/3 Month vs. 3.6mg/Month in ER +ve EBC Pre-menopausal Patients

Who this might be right for
Breast Cancer
AstraZeneca 170
Large-scale testing (Phase 3)WithdrawnNCT03658213
What this trial is testing

To Compare ZOLADEX 10.8 mg With ZOLADEX 3.6mg in Chinese Pre-menopausal ER+ HER2- Early Breast Cancer.

Who this might be right for
Breast Cancer
AstraZeneca
Very early researchEnded earlyNCT00651976
What this trial is testing

Letrozole in Treating Postmenopausal Women With Stage I, II or III Breast Cancer That Can Be Removed by Surgery

Who this might be right for
Breast Cancer
Vanderbilt-Ingram Cancer Center 213
Load More Results